| UBS Group AG |
Ordinary Shares |
12.8 |
2024-04-1515 April 2024 |
| UBS Group AG |
Ordinary Shares |
11.9 |
2024-04-1212 April 2024 |
| Liu, Dianbo, 刘殿波 |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Ginkgo (PTC) Limited |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Luye Pharma Holdings Ltd. |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| LuYe Pharmaceutical International Co., Ltd. |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| LuYe Pharmaceutical Investment Co., Ltd. |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Luye Life Sciences Group Ltd |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Nelumbo Investments Limited |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Shorea LBG |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Liu, Dianbo, 刘殿波 |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Luye Life Sciences Group Ltd |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Ginkgo (PTC) Limited |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Shorea LBG |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Nelumbo Investments Limited |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| UBS Group AG |
Ordinary Shares |
12.6 |
2024-04-1010 April 2024 |
| LuYe Pharmaceutical Investment Co., Ltd. |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| Luye Pharma Holdings Ltd. |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| LuYe Pharmaceutical International Co., Ltd. |
Ordinary Shares |
33.5 |
2024-04-1010 April 2024 |
| UBS Group AG |
Ordinary Shares |
13 |
2024-04-0909 April 2024 |